Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current Assets
QFR215385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
81,693.00
Year-over-Year Change
-7.34%
Date Range
10/1/2000 - 1/1/2025
Summary
This economic indicator tracks the current assets of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides insight into the financial health and liquidity of a critical sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the total value of short-term assets held by pharmaceutical companies that can be converted to cash within one year. Economists use this metric to assess sector financial performance, investment potential, and overall economic resilience.
Methodology
Data is collected through comprehensive quarterly financial reporting by corporations in the pharmaceutical and medicine manufacturing sector.
Historical Context
This indicator is used by investors, policymakers, and financial analysts to evaluate sector-specific economic trends and potential market developments.
Key Facts
- Represents short-term financial resources in pharmaceutical corporations
- Provides quarterly snapshot of sector financial health
- Includes assets that can be quickly converted to cash
FAQs
Q: What does 'All Other Current Assets' include?
A: It includes short-term assets like accounts receivable, inventory, prepaid expenses, and other liquid financial resources not categorized in primary asset classes.
Q: Why are current assets important for pharmaceutical companies?
A: Current assets indicate a company's ability to fund operations, invest in research, and manage short-term financial obligations.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a consistent and timely view of the sector's financial condition.
Q: How do investors use this trend?
A: Investors analyze this trend to assess the financial stability and potential growth of pharmaceutical companies and the broader healthcare sector.
Q: What are the limitations of this data?
A: The data represents a snapshot in time and should be considered alongside other financial metrics for comprehensive analysis.
Related Trends
Quarterly Financial Report: U.S. Corporations: Scientific Research and Development Services: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301547USNO
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319545USNO
Quarterly Financial Report: U.S. Corporations: Chemicals: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102CHEUSNO
Quarterly Financial Report: U.S. Corporations: All Nondurable Manufacturing: Net Income Retained in Business
QFRNIRBNDUUSNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Total Current Assets
QFRTCATRAUSNO
Quarterly Financial Report: U.S. Corporations: Computer and Electronic Products: Trade Accounts and Trade Notes Payable
QFR306COMUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Current Assets [QFR215385USNO], retrieved from FRED.
Last Checked: 8/1/2025